Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
V-Bio Venturesv-bio.ventures · Low evidenceV-Bio Ventures is a life science venture capital fund that co-creates startups and invests in early- to mid-stage therapeutics companies with high growth potential, turning scientific innovations into products that improve lives. It leverages a broad European network—including a preferred relationship with Belgium’s VIB—to source deals from research institutes and spin-outs across Europe and beyond, offering more than capital to portfolio companies. With about €186 million under management across two funds and a diverse investor base including InnovFin/EFSI, V-Bio focuses on private companies addressing unmet therapeutic needs and related technologies.
Parse Score